L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]-

Request For Quotation
L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Basic information
Product Name:L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]-
Synonyms:L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]-;910;SDZ 283;SDZ283;SDZ-283
CAS:164514-54-9
MF:C46H59N5O9
MW:825.99
EINECS:
Product Categories:
Mol File:164514-54-9.mol
L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Structure
L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Chemical Properties
Boiling point 1059.7±65.0 °C(Predicted)
density 1.202±0.06 g/cm3(Predicted)
pka9.27±0.35(Predicted)
Safety Information
MSDS Information
L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Usage And Synthesis
DescriptionSDZ 283-910 is a statine-derived inhibitor .
UsesSDZ283-910 is a potent human immunodeficiency virus type-1 (HIV-1) protease inhibitor[1].
IC 50HIV-1
References[1] S Ringhofer, et al. X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: agreement of time-resolved spectroscopy and molecular dynamics simulations. J Mol Biol. 1999 Mar 5;286(4):1147-59. DOI:10.1006/jmbi.1998.2533
L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Preparation Products And Raw materials
Tag:L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]-(164514-54-9) Related Product Information
Ritonavir Ivermectin PLERIXAFOR Gag-Pol polyprotein, HIV (440a.a, His) P24 protein, HIV-1 (BAH97658, HIS) Rev Protein, HIV-1 group M subtype C (GST)